Hôpital Pellegrin, Bordeaux, FRANCE

Academic/Hospital

Also known as: CHU Bordeaux Pellegrin | CIC SANPSY (USR CNRS 3413), Groupe Hospitalier Pellegrin, Bordeaux, France | CIC SANPSY (USR CNRS 3413), Hôpital Pellegrin, Bordeaux, FRANCE | Hôpital Pellegrin

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Feb 6, 2018

Last known activity

May 29, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

bp1.4979

Other trials (1 own, 0 via acquisition)

prednisolone

Indications

Studied for

Psychomotor Agitation
Restless Legs Syndrome
Syndrome

Recent trials (2)

NCT03415828Study chairN/AMay 29, 2018
NCT03345953Overall official - principal investigatorPhase 2Feb 6, 2018

Details

Last known activity: May 29, 2018